FGF9 and pleuropulmonary blastoma: Taken together, the data indicate that PPB exhibits a distinctive molecular signature when compared to CPAM, which includes the ligands FGF9 and SHH as well as the lung epithelial transcriptional regulators ETV4, ETV5, ELF5, IRX2 and IRX5.